You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
華大智造(688114.SH):基因測序儀業務海外收入佔比正逐漸提升,2022年已上升到34%
格隆匯 05-04 09:27

格隆匯5月4日丨華大智造(688114.SH)於2023年4月25日-4月28日開展投資者交流活動,與投資者進行互動交流,就投資者關注的問題在信息披露允許的範圍內進行了回答。

就“2022年基因測序業務板塊情況如何?”,公司回覆稱,隨着與Illumina訴訟的逐步和解及渠道佈局的進一步完善,海外市場正在快速地打開。基因測序儀業務海外收入佔比正逐漸提升,2022年已上升到34%。具體來看,2022年亞太區實現收入2.9億元,同比增長18%;歐非區實現收入2.5億元,同比增長84%;美洲區域實現收入0.6億元,同比增長228%;國內區域實現收入11.6億元,同比增長32%。

從產品類型來看,2022年基因測序儀設備實現收入7.6億元,同比增長63%。截止2022年底,各型號測序儀累計裝機超過2500台,而裝機量的快速提升也帶動了試劑耗材增長。2022年試劑耗材收入實現9.8億元,同比增長27%。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account